A continuous method for the large-scale extraction of plasmid DNA by modified boiling lysis

This protocol describes a streamlined method of plasmid DNA extraction by continual thermal lysis, a modification of the basic boiling lysis technique, to simplify the processing of large volumes of Escherichia coli cultures. Fermented bacteria are harvested using a hollow fiber-membrane module and pre-treated with lysozyme prior to passing through a thermal exchange coil set at 70 °C to lyse the cells, and into a juxtaposed cooling coil on ice. The lysed and cooled bacteria are subsequently separated from the lysate by centrifugation and plasmid DNA is precipitated from the supernatant for further purification. The use of peristaltic pumps and two heating coils at constant temperature without the use of centrifugation enable the lysis process to become constant and controllable, providing a flow-through protocol for cell lysis and plasmid DNA extraction. Large volumes of bacterial cultures (20 l) can be processed in 2 h, yielding approximately 100 mg plasmid DNA l −1 culture, making this an attractive protocol for consistent and large-scale preparation of plasmid DNA.

Similar content being viewed by others

Agarose gel microcapsules enable easy-to-prepare, picolitre-scale, single-cell genomics, yielding high-coverage genome sequences

Article Open access 18 October 2022

Cascaded processing enables continuous upstream processing with E. coli BL21(DE3)

Article Open access 01 June 2021

Length-based separation of Bacillus subtilis bacterial populations by viscoelastic microfluidics

Article Open access 19 January 2022

Introduction

Recent progresses in the development of DNA vaccination and gene therapy show great potential for the treatment of disease. As clinical application of these technologies will require large quantities of plasmid DNA at the milligram level, there is an increased demand for large quantities of recombinant plasmid DNA 1,2 . Thus, developing a large-scale, reproducible and cost-effective protocol for plasmid DNA preparation is now one of the most challenging tasks in DNA vaccine development 3,4,5 .

Target DNA sequences can be amplified to produce large quantities of purified DNA for use in such applications as gene therapy by ligation into a plasmid vector, which can then be transformed into suitable bacterial cells. These recombinant bacterial strains will replicate the plasmid, producing large quantities of the target DNA 6 . A typical process of plasmid DNA generation includes the construction and selection of appropriate expression vectors, production of recombinant microorganisms and cell growth, followed by lysis of the cells, and the extraction and purification of plasmid DNA 7 . When the plasmids are extracted and purified, they usually result in one of two forms: either open-circled or supercoiled. However, when they are used in gene therapy or vaccine immunization, the plasmid with the supercoiled form is preferred. During plasmid DNA extraction, the step of lysing bacterial cells without losing plasmids is probably the most critical for downstream processing 8 , as the quantity of plasmid DNA recovered is mostly determined by this step after fermentation 9,10 .

Plasmid DNA extraction from bacterial cells usually begins with a chemical lysis step 6 , such as alkaline lysis 11 , which is a widely adopted method in research laboratories. However, during alkaline lysis, precipitates form that contain cell debris, denatured proteins and nucleic acids, which must be removed. Centrifugation on a fixed-angle rotor is the most common operation during this process 12,13 and is a rate-limiting step for a large-scale preparation 14 . An alternative method is boiling lysis, in which the 100 °C thermal treatment disrupts and makes cells release the plasmid DNA 15 . Although boiling lysis can isolate more plasmids than alkaline lysis, the inconsistent plasmid yield and purity, and the difficulty in operation, make this method undesirable even for laboratory research-scale preparations 16 . For large-scale production, a high-pressure homogenizer is used to continuously disrupt cells 17 . However, this often causes problems in collecting fragmented DNA plasmids and more contaminated genomic DNA due to its severe fluid dynamic forces for destruction 17 . Therefore, the development of a highly efficient continuous lysis and scalable protocol becomes a challenging but important issue.

Based on the conventional boiling lysis protocol 18 , Lee and Lander have made several modifications to improve the method 19,20 . Although these modifications significantly improve the efficiency of boiling lysis and the yield of plasmid DNA, they require centrifugation steps at the bacterial-collecting and plasmid-extracting stage, special equipment and reagents. In a recent report 21 , we described a design for a flow-through protocol from cultured bacteria for the extraction of plasmid DNA. The schematic design of the device and set-up is shown in Figure 1. The use of a 0.2 μm pore size hollow fiber-membrane module to harvest the fermented bacteria will minimize the centrifugation step, which is one of the limiting steps in large-scale preparation. Pumping through the heat-exchanging coils, cells receive uniform thermal treatment regardless of the volume of the sample, which ensures continuity and homogeneity of cell lysis. The diameter of copper coils can vary, depending on the volume of fermentation. This provides versatility for any given volume of samples. This protocol does not aim to increase the yield of plasmid, but to provide consistency between batches, which can otherwise be lacking in boiling lysis methods. A centrifugation step is, however, still required to separate the plasmid-containing supernatant from the lysed bacteria, which will require further optimization. Overall, this protocol provides a scalable, efficient and cost-effective preparation system to meet the needs of large-scale plasmid production for both laboratories and industry. The protocol mainly details the lysis of cells and the extraction of plasmid DNA, and although further purification procedures may be required, they are not explained in detail within this protocol.

figure 1

Materials

Reagents

Critical

The following plasmids have been extracted using this protocol: pcDNA3, pGEX-4T-1, pVAX1 and pcD-VP1. The latter, encoding a capsid protein VP1 (639 bp) of foot and mouth disease virus (FMDV; described previously 22 ), was extensively used during the optimization of this protocol.

figure 2

Critical Step

Adjust the flow rate using a stop watch so that the bacteria pass through the heated coil within 20 s. We have found this to be an optimal time period for the thermal lysis of cells; however, other times may be tested if an optimal yield can not be obtained. As indicated in Figure 2, the temperatures of 70 °C and 80 °C achieved a higher yield of plasmids with a minimum contamination with genomic DNA. However, 70 °C is probably the most appropriate setting in terms of the balance between energy costs and the quality of plasmids produced. An immediate connection from the heating coil to the coil submerged in ice should be used to avoid excess lysis.

Plasmid isolation (see Fig. 1)

  1. 16 Lysed bacteria are centrifuged at 12,000g for 30 min.
  2. 17 To precipitate the plasmid DNA from the supernatant in a floc form, transfer the supernatant into a clean flask (C5) containing 0.1 volume of NaOAc (3 M, pH 5.2) and 0.6 volume of isopropyl alcohol, and incubate at room temperature for 20 min.

Critical Step

To obtain perfect floc precipitates, do not vigorously shake the mixture of plasmid after adding isopropyl alcohol. If a high yield of plasmid is obtained from the precipitation, the incubation time can be reduced, as appropriate, and white floc can be immediately collected by passing through the 200 mesh nylon filter.

Pause point

The dry precipitates can be stored at 4 °C for weeks.

Critical Step

Dipping the bucket into 70% ethanol several times can enable effective rinsing. This will remove contamination as the dipping action will disassociate substances from the plasmid floc. Rinsing with 70% ethanol is important to eliminate impure substances, such as RNAs; sometimes, an additional rinse with chloroform before the 70% ethanol washes will remove some of the protein or lipid contamination.

Plasmid purification

  1. 20 The precipitates collected are re-suspended with 1–5 ml of TE buffer.
  2. 21 Purification of plasmid DNA can be performed using either option A or B:
    1. A Purification by PEG precipitation
      1. i Mix with the same volume of 13% PEG 8000 (in 1.6 M NaCl solution).
      2. ii Centrifuge at 15,000g at room temperature for 10 min.
      3. iii Dissolve purified plasmid DNA in fresh 1 ml TE buffer and the plasmid can be stored at −20 °C for long-term storage.
      1. i The purification method can be adapted to be used with any available commercial purification column, such as the one made by Qiagen.

      Agarose gel electrophoresis to measure plasmid quality

      1. 22 Digest the plasmid with the restriction enzymes EcoRI and XbaI for 2–3 h, and the reaction should be stopped by incubation at 60 °C for 10 min.
      2. 23 Load the digestion reaction onto 0.7% agarose gel containing 0.05 μg ml −1 of ethidium bromide, covering with TBE buffer to perform electrophoresis for 1 h at 60 V.

      Critical Step

      The appropriate concentration of agarose gel should be based on the size of the tested plasmid.

      Quantitative measures of plasmids using agarose gel electrophoresis

      1. 26 The plasmid is serially diluted 1:1 with TE buffer and subjected to 0.7% agarose gel electrophoresis (as in Step 23), along with a standard DNA marker with a known concentration. All bands are visualized under UV light after staining with ethidium bromide and visualized on a UV transilluminator. Photographic records obtained from a digital camera (Olympus) are analyzed using Quantity One software (Bio-Rad) by comparing the intensity of the known concentration of marker DNA as a reference with the plasmid to determine the concentration of the tested plasmid.

      Troubleshooting

      Troubleshooting advice can be found in Table 2.

      figure 3

      References

      1. Prather, K., Sagar, S., Murphy, J. & Chartrain, M. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification. Enzy. Microbial Technol.33, 865–883 (2003). ArticleCASGoogle Scholar
      2. Luo, D. & Saltzman, W.M. Synthetic DNA delivery systems. Nature Biotechnol.18, 33–37 (2000). ArticleCASGoogle Scholar
      3. Schleef, M. Biotechnology 2nd edn (Wiley-VCH, New York, 1999). Google Scholar
      4. Eastman, E.M. & Durland, R.H. Manufacturing and quality control of plasmid-based gene expression systems. Adv. Drug Deliv. Rev.30, 33–48 (1998). ArticleCASGoogle Scholar
      5. Levy, M.S., O'Kennedy, R.D., Ayazi-Shamlou, P. & Dunnill, P. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends Biotechnol.18, 296–305 (2000). ArticleCASGoogle Scholar
      6. Birnboim, H.C. & Doly, J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl. Acids Res.7, 1513–1523 (1979). ArticleCASGoogle Scholar
      7. Ferreia, G., Monteiro, G., Prazeres, D. & Cabral, J. Downstream processing of plasmid DNA for gene therapy and DNA vaccine application. Trends Biotechnol.18, 380–388 (2000). ArticleGoogle Scholar
      8. Prazeres, D.M., Ferreira, G.N., Monteiro, G.A., Cooney, C.L. & Cabral, J.M. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol.17, 169–174 (1999). ArticleCASGoogle Scholar
      9. Levy, M. Effect of shear on plasmid DNA solution. Bioprocess. Eng.20, 7–13 (1999). ArticleCASGoogle Scholar
      10. Ciccolini, L.A., Shamlou, P.A., Titchener-Hooker, N.J., Ward, J.M. & Dunnill, P. Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release. Biotechnol. Bioeng.60, 768–770 (1998). ArticleCASGoogle Scholar
      11. Lahijani, R., Hulley, G., Soriano, G., Horn, N.A. & Marquet, M. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum. Gene Ther.7, 1971–1980 (1996). ArticleCASGoogle Scholar
      12. Prazeres, D.M., Schluep, T. & Cooney, C. Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography. J. Chromatogr. A806, 31–45 (1998). ArticleCASGoogle Scholar
      13. Kelly, B. & Hatton, T. The fermentation/downstream processing interface. Bioseparation1, 333–349 (1991). Google Scholar
      14. Theodossiou, I. The processing of plasmid based gene from Escherichia coli: primary recovery by filtration. Bioprocess. Eng.16, 175–183 (1997). CASGoogle Scholar
      15. Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989). Google Scholar
      16. Wang, B., Merva, M., Williams, W.V. & Weiner, D.B. Large-scale preparation of plasmid DNA by microwave lysis. Biotechniques18, 554–555 (1995). CASPubMedGoogle Scholar
      17. Clemson, M. & Kelly, W.J. Optimizing alkaline lysis for DNA plasmid recovery. Biotechnol. Appl. Biochem.37, 235–244 (2003). ArticleCASGoogle Scholar
      18. Holmes, D.S. & Quigley, M. A rapid boiling method for the preparation of bacterial plasmids. Anal. Biochem.114, 193–197 (1981). ArticleCASGoogle Scholar
      19. Lee, A.L. & Sagar, S. A Method for Large-Scale Plasmid Purification (Patent 6,197,553, 2001) (Merck Co. Inc., USA).
      20. Lander, R., Winters, M., Meacle, F., Buckland, B. & Lee, A.L. Fractional precipitation of plasmid DNA from lysate by CTAB. Biotechnol. Bioeng.79, 776–784 (2004). ArticleGoogle Scholar
      21. Zhu, K. et al. A continuous thermal lysis procedure for the large-scale preparation of plasmid DNA. J. Biotechnol.118, 257–264 (2005). ArticleCASGoogle Scholar
      22. Jin, H. et al. Effect of chemical adjuvants on DNA vaccination. Vaccine22, 2925–2935 (2004). ArticleCASGoogle Scholar
      23. Jin, H. et al. Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem. Biophys. Res. Commun.328, 979–986 (2005). ArticleCASGoogle Scholar

      Acknowledgements

      This work was supported, in part, by the China High Technology '863' Project (2004AA213102 and 2003AA241110), the China Key Technologies R&D program and a special research fund to B.W. provided by China Agricultural University. We would also like to thank Dr Jane Q.L. Yu for her assistance with the work, and Dr Terry Ng for his critical reading and valuable suggestions for the manuscript.

      Author information

      Authors and Affiliations

      1. The People's Hospital of Xinjiang Uygur Autonomous Region, 91 Tianchi Road, Urmuqi, 830001, China, Xinjiang Kaichun Zhu
      2. State Key Laboratory for Agro-Biotechnology and the Key Laboratory of Agro-Microbial Resources and Applications of MOA, China Agricultural University, Beijing, 100094, China Huali Jin, Zhonghuai He, Qinghong Zhu & Bin Wang
      1. Kaichun Zhu